CORCEPT THERAPEUTICS INC Common Stock, Value, Issued
CORCEPT THERAPEUTICS INC (CORT) had Common Stock, Value, Issued of $142.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-07-29
- 2026-06-30: Common Stock, Value, Issued $142.00K.
- 2025-12-31: Common Stock, Value, Issued $140.00K.
- 2025-09-30: Common Stock, Value, Issued $139.00K.
- 2025-06-30: Common Stock, Value, Issued $138.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-06-30 | $142.00K 10-Q · filed 2026-07-29 |
| 2025-12-31 | $140.00K 10-Q · filed 2026-07-29 |
| 2025-09-30 | $139.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $138.00K 10-Q · filed 2025-07-31 |
| 2024-12-31 | $136.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $135.00K 10-Q · filed 2024-10-30 |
| 2024-06-30 | $134.00K 10-Q · filed 2024-07-29 |
| 2023-12-31 | $133.00K 10-Q · filed 2024-10-30 |
| 2023-09-30 | $133.00K 10-Q · filed 2023-11-01 |
| 2023-06-30 | $132.00K 10-Q · filed 2023-08-02 |
| 2023-03-31 | $131.00K 10-Q · filed 2023-05-03 |
| 2022-12-31 | $131.00K 10-Q · filed 2023-11-01 |
| 2022-09-30 | $130.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $128.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $128.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $127.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $126.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $125.00K 10-Q · filed 2021-07-29 |
| 2021-03-31 | $124.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $122.00K 10-K · filed 2022-02-15 |
| 2020-09-30 | $121.00K 10-Q · filed 2020-11-03 |
| 2020-06-30 | $121.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $120.00K 10-Q · filed 2020-05-04 |
| 2019-12-31 | $120.00K 10-K · filed 2021-02-23 |
| 2019-09-30 | $119.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $118.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $118.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $117.00K 10-K · filed 2020-02-24 |
| 2018-09-30 | $116.00K 10-Q · filed 2018-11-02 |
| 2018-06-30 | $116.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $115.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $115.00K 10-K · filed 2019-02-26 |
| 2017-09-30 | $114.00K 10-Q · filed 2017-11-03 |
| 2017-06-30 | $113.00K 10-Q · filed 2017-08-02 |
| 2017-03-31 | $113.00K 10-Q · filed 2017-05-02 |
| 2016-12-31 | $113.00K 10-K · filed 2018-02-28 |
| 2016-09-30 | $111.00K 10-Q · filed 2016-11-02 |
| 2016-06-30 | $110.00K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $110.00K 10-Q · filed 2016-05-04 |
| 2015-12-31 | $110.00K 10-K · filed 2017-03-06 |
| 2015-09-30 | $109.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $108.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $108.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $101.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | $101.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $101.00K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $101.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $100.00K 10-K · filed 2015-03-13 |
| 2013-09-30 | $100.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $100.00K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $100.00K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $100.00K 10-K · filed 2014-03-14 |
| 2012-09-30 | $100.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $89.00K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $89.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $84.00K 10-K · filed 2013-03-15 |
| 2011-09-30 | $84.00K 10-Q · filed 2011-11-08 |
| 2011-06-30 | $84.00K 10-Q · filed 2011-08-09 |
| 2010-12-31 | $72.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |